Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SKI-interacting protein pseudogene (ENSG00000235400, LOC652549) is a genomic sequence similar to the functional SKI-interacting protein gene (often abbreviated as SKIP or SNW1) but is classified as a pseudogene. Pseudogenes can arise from duplication or retrotransposition events and generally do not encode functional proteins due to accumulated mutations or lack of transcription[1]. The SKI-interacting protein itself is a well-studied coactivator and corepressor, regulating transcription and interacting with nuclear receptors and other transcriptional machinery[3][5]. However, this pseudogene form does not have a defined biological activity or role as a drug target, and its mention may be due to annotation artifacts or misidentification, not to genuine therapeutic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SKI-interacting protein pseudogene.